Hamps Bio Limited
₹ 60.0
1.97%
05 Sep
- close price
About
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution[1]
Key Points
- Market Cap ₹ 26.1 Cr.
- Current Price ₹ 60.0
- High / Low ₹ 107 / 34.2
- Stock P/E 87.1
- Book Value ₹ 20.2
- Dividend Yield 0.00 %
- ROCE 6.68 %
- ROE 4.94 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.1% over last 3 years.
- Company might be capitalizing the interest cost
- Working capital days have increased from 40.4 days to 124 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 5.34 | 5.58 | 6.48 | 6.67 | |
| 4.72 | 4.71 | 5.31 | 5.90 | |
| Operating Profit | 0.62 | 0.87 | 1.17 | 0.77 |
| OPM % | 11.61% | 15.59% | 18.06% | 11.54% |
| 0.00 | 0.01 | 0.03 | 0.15 | |
| Interest | 0.19 | 0.18 | 0.15 | 0.14 |
| Depreciation | 0.33 | 0.34 | 0.40 | 0.38 |
| Profit before tax | 0.10 | 0.36 | 0.65 | 0.40 |
| Tax % | -20.00% | 0.00% | 23.08% | 25.00% |
| 0.12 | 0.36 | 0.50 | 0.30 | |
| EPS in Rs | 0.80 | 2.40 | 2.55 | 0.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 8% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 36% |
| TTM: | -40% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 1.50 | 1.50 | 1.96 | 4.36 |
| Reserves | -0.49 | -0.14 | 1.38 | 4.44 |
| 2.04 | 1.74 | 1.05 | 2.97 | |
| 0.60 | 0.86 | 0.73 | 0.97 | |
| Total Liabilities | 3.65 | 3.96 | 5.12 | 12.74 |
| 2.15 | 2.61 | 2.52 | 2.43 | |
| CWIP | 0.00 | 0.00 | 0.00 | 3.38 |
| Investments | 0.04 | 0.00 | 0.00 | 0.00 |
| 1.46 | 1.35 | 2.60 | 6.93 | |
| Total Assets | 3.65 | 3.96 | 5.12 | 12.74 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 0.33 | 1.23 | -0.29 | -1.77 | |
| 0.51 | -0.75 | -0.37 | -6.20 | |
| -0.94 | -0.48 | 0.67 | 8.00 | |
| Net Cash Flow | -0.10 | 0.00 | 0.01 | 0.04 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 47.16 | 49.71 | 55.76 | 65.12 |
| Inventory Days | 94.57 | 75.03 | 264.09 | 452.45 |
| Days Payable | 63.05 | 103.42 | 60.12 | 114.06 |
| Cash Conversion Cycle | 78.69 | 21.32 | 259.73 | 403.51 |
| Working Capital Days | -34.86 | -58.22 | 55.20 | 124.22 |
| ROCE % | 17.56% | 21.36% | 6.68% |
Documents
Announcements
-
Revised Record Date For Bonus Issue
1d - Board-approved 1:1 bonus shares; record date revised to September 9, 2025; shareholder approval Aug 30, 2025.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 1 Sep
- Fixed Record Date For Bonus Issue 1 Sep
- Shareholder Meeting / Postal Ballot-Outcome of AGM 30 Aug
-
Announcement under Regulation 30 (LODR)-Change in Management
25 Aug - Appointed Ms. Shivali Rajpurohit as Independent Director from Aug 25, 2025 for five years; committees reconstituted.
Business Overview:[1]
HBL is in the business of ethical marketing and distribution of pharmaceutical formulations across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine & nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers.